Telomir Pharmaceuticals, Inc. (TELO) stock

TELONasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30

$0.50−0.09 (-15.90%)

Close on Nov 12, 2026Market cap $34.42MP/E –Yield –

Telomir Pharmaceuticals operating margin

Operating margin is operating income as a percentage of revenue.

Telomir Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?